Ledipasvir + Sofosbuvir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Ledipasvir ledipasvir
Sofosbuvir sofosbuvir

Brands with this exact combination

Brand	Composition & strength	Manufacturer
ledipasvir and sofosbuvirUS	45 mg / 200 mg / 90 mg / 400 mg / 33.75 mg / 150 mg	Gilead Sciences, Inc
Ledipasvir 90mg / Sofosbuvir 400mg tabletsES GB	90 mg / 400 mg / 45 mg / 200 mg	Gilead Sciences Ltd
Harvoni 33.75mg/150mg granules sachetsGB	powder Ledipasvir 33.75 mg + Sofosbuvir 150 mg powder Ledipasvir 45 mg + Sofosbuvir 200 mg	Gilead Sciences Ltd
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar freeGB	33.75 mg / 150 mg / 45 mg / 200 mg	Gilead Sciences Ltd
JARVONIMX	tablet Ledipasvir + Sofosbuvir	Gilead Sciences Ireland UC.
夏奉寧膜衣錠TW	tablet Ledipasvir + Sofosbuvir	香港商吉立亞醫藥有限公司台灣分公司
HARVONI 90 mg/400 mg, comprimé pelliculéFR	tablet Ledipasvir 90 mg + Sofosbuvir 400 mg	GILEAD SCIENCES IRELAND UC (IRLANDE)

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

ES · HARVONI · 1 products · record
GB · HARVONI; Harvoni 33.75mg/150mg granules sachets · 4 products · record
US · HARVONI · 5 products · record
CA · HARVONI · 1 products · record

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.